Accession Number: | 0001193805-21-000866 |
Date: | 2021-06-10 |
Issuer: | IMMUNIC, INC. (IMUX) |
Original Submission Date: |
PHILLIPS BARCLAY A
1200 AVENUE OF THE AMERICAS, SUITE 200
NEW YORK, NY 10036
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION | 14.77 | 2021-06-10 | deemed execution date | A | 10,000 (a) | 2031-06-10 | common stock 10,000 | $14.77 | 10,000 | direct |
ID | footnote |
---|---|
f1 | the option vests in monthly increments over a period of one year from the grant date. |